InsidersTradesSigma
Follow the 奥锐特 share price and the full insider trade history of the company, a listed issuer based in China. Shares are quoted on the CN market, under the oversight of SSE / SZSE (CSRC). Operating in the Health Care sector, 奥锐特 has recorded 12 insider filings. Market capitalisation: €7.9bn. The latest transaction was filed on 10 March 2026 (Sale). Among the most active insiders: 邱培静. All data is free.
12
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€6m
12 ops.
Sell Volume
11Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 7,230 of 29,063 companies
64.1
score / 100
Value52
Quality76
FCF yld0.9%
Earn yld5.7%
EV/EBITDA13.1x
ROE15%
Gross mgn60%
Net mgn26%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 10 March 2026
Declarations12 total
12 of 12 declarations
关于 奥锐特
奥锐特是一家在上海证券交易所上市的医疗保健和制药领域的公司。它专注于创新药物的开发和商业化。